Progressive Hemorrhage and Myotoxicity Induced by Echis carinatus Venom in Murine Model: Neutralization by Inhibitor Cocktail of N,N,N',N'-Tetrakis (2-Pyridylmethyl) Ethane-1,2-Diamine and Silymarin.
Viperbite is often associated with severe local toxicity, including progressive hemorrhage and myotoxicity, persistent even after the administration of anti-snake venom (ASV). In the recent past, investigations have revealed the orchestrated actions of Zn2+ metalloproteases (Zn2+MPs), phospholipase A2s (PLA2s) and hyaluronidases (HYs) in the onset and progression of local toxicity from the bitten site. As a consequence, venom researchers and medical practitioners are in deliberate quest of potent molecules alongside ASV to tackle the brutal local manifestations induced by aforesaid venom toxins. Based on these facts, we have demonstrated the protective efficacy of inhibitor cocktail containing equal ratios of N,N,N',N'-tetrakis (2-pyridylmethyl) ethane-1,2-diamine (TPEN) and silymarin (SLN) against progressive local toxicity induced by Echis carinatus venom (ECV). In our previous study we have shown the inhibitory potentials of TPEN towards Zn2+MPs of ECV (IC50: 6.7 μM). In this study we have evaluated in vitro inhibitory potentials of SLN towards PLA2s (IC50: 12.5 μM) and HYs (IC50: 8 μM) of ECV in addition to docking studies. Further, we have demonstrated the protection of ECV induced local toxicity with 10 mM inhibitor cocktail following 15, 30 min (for hemorrhage and myotoxicity); 60 min (for hemorrhage alone) of ECV injection in murine model. The histological examination of skin and thigh muscle sections taken out from the site of ECV injection substantiated the overall protection offered by inhibitor cocktail. In conclusion, the protective efficacy of inhibitor cocktail is of high interest and can be administered locally alongside ASV to treat severe local toxicity.
Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru, Karnataka, India.
Ankanahalli N
AN
Nanjaraj Urs
Centre of Advanced Study in Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai, Tamil Nadu, India.
Chandrasekaran
C
Ramakrishnan
Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru, Karnataka, India.
Vikram
V
Joshi
Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru, Karnataka, India.
Kanve Nagaraj
KN
Suvilesh
Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru, Karnataka, India.
Teregowda
T
Veerabasappa Gowda
Centre of Advanced Study in Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai, Tamil Nadu, India; Bioinformatics Infrastructure Facility, University of Madras, Guindy Campus, Chennai, Tamil Nadu, India.
Devadasan
D
Velmurugan
Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru, Karnataka, India.
Bannikuppe Sannanaik
BS
Vishwanath
D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005021:Ethylamines / Q000494:pharmacology*; D008297:Male; D051379:Mice; D011725:Pyridines / Q000494:pharmacology*; D012838:Silymarin / Q000494:pharmacology*; D014757:Viper Venoms / Q000633:toxicity*; D017819:Viperidae
D004791:Enzyme Inhibitors; D005021:Ethylamines; C511824:N,N,N',N'-tetrakis(2-pyridylmethyl)ethane-1,2-diamine; D011725:Pyridines; D012838:Silymarin; D014757:Viper Venoms